SORT1 rs599609: Understanding Your Genetic Association
The rs599609 variant is a genetic marker located in the 1p13 region of the human genome, a locus well-known for its strong association with plasma low-density lipoprotein cholesterol (LDL-C) levels. Research indicates that this variant sits near the SORT1 gene, which plays a significant role in lipid metabolism and cardiovascular disease risk.
What each genotype means
Higher LDL-C risk profile
This genotype is associated with higher levels of plasma low-density lipoprotein cholesterol (LDL-C) and a statistically increased risk of coronary artery disease compared to those carrying the minor allele. Research indicates this variant influences the hepatic expression of the SORT1 gene, which plays a role in lipoprotein metabolism. Please discuss your lipid profile and cardiovascular health with your clinician.
This is the major genotype, carried by the majority of individuals of European ancestry.
Intermediate LDL-C risk profile
This genotype represents a heterozygous state associated with intermediate levels of LDL-C and coronary artery disease risk compared to the homozygous major and minor genotypes. The variant is thought to modulate SORT1 expression, affecting how the liver processes lipoproteins. Please discuss your lipid profile and cardiovascular health with your clinician.
This genotype is common, appearing in a significant portion of the population across many ancestries.
Lower LDL-C risk profile
This genotype is associated with lower levels of plasma LDL-C and a reduced statistical risk of coronary artery disease compared to individuals homozygous for the major allele. The presence of this variant is linked to altered hepatic SORT1 expression, which may influence lipoprotein secretion. Please discuss your lipid profile and cardiovascular health with your clinician.
The minor allele frequency is approximately 20-25% in European populations, making this homozygous genotype less common than the others.
What is the rs599609 Variant?
The rs599609 variant is a single nucleotide polymorphism (SNP) located on chromosome 1 at the 1p13.3 locus. This specific region of the genome is highly significant in genetic research because it sits in a non-coding area nestled between several genes, including SORT1, PSRC1, and CELSR2. Because these genes are clustered so closely together, scientists have spent years investigating which specific gene is responsible for the observed effects on cholesterol. The rs599609 variant serves as a marker for this entire genomic neighborhood. When researchers perform genome-wide association studies (GWAS), they often identify this locus as one of the most influential genetic signals for lipid traits. It is important to understand that this variant is not a 'disease gene' in the sense that it causes a condition on its own; rather, it is a statistical marker that helps researchers identify individuals who may have a different genetic predisposition toward how their body processes cholesterol.
The Role of the SORT1 Gene
The SORT1 gene encodes a protein called sortilin, which acts as an intracellular sorting receptor. Sortilin is involved in the trafficking of various proteins within cells, including those related to lipid metabolism. Research has shown that sortilin interacts with apolipoprotein B100, a key component of VLDL, which is the precursor to LDL cholesterol. By regulating the secretion of these particles from the liver, sortilin influences the amount of LDL-C that circulates in the bloodstream. Some studies suggest that higher expression of SORT1 in the liver may reduce the production of VLDL, thereby lowering LDL-C levels, while other models suggest more complex interactions. Because the rs599609 variant is located in a regulatory region near this gene, it is believed to influence how much sortilin is produced. This makes the SORT1 gene a primary candidate for explaining why this specific genomic locus has such a profound impact on cholesterol levels and, by extension, cardiovascular health.
Research and Cardiovascular Associations
The association between the 1p13 locus and cardiovascular health is supported by extensive research. Since its identification in the 2007 Wellcome Trust Case Consortium study, this region has been consistently linked to coronary artery disease and myocardial infarction across diverse populations. The evidence for its association with LDL-C levels is considered strong, as it has been replicated in numerous large-scale GWAS across European, East Asian, South Asian, and African American cohorts. However, while the statistical association is robust, the biological mechanism remains a subject of active investigation. Because the variant is located in a non-coding region, it likely acts by altering gene expression (an eQTL effect) rather than changing the structure of a protein directly. While the link to cholesterol is clear, the clinical utility of this information is still evolving. It is considered a risk factor, but it is only one piece of a much larger puzzle that includes diet, lifestyle, and other genetic and environmental factors.
Interpreting Your Genetic Information
If you have received information about your rs599609 genotype, it is important to view it in the context of your overall health profile. This variant is a common genetic marker, and having a specific genotype does not mean you will develop cardiovascular disease, nor does it guarantee you will have high or low cholesterol. Genetic associations are statistical probabilities observed across large populations, not individual medical predictions. You cannot use this information to diagnose yourself or to make decisions about medication. If you are concerned about your cholesterol levels or your risk for heart disease, the most effective steps involve consulting with a healthcare professional. They can evaluate your lipid panels, family history, and lifestyle factors to provide personalized guidance. Never change or stop taking any prescribed medications based on genetic test results without first discussing the matter with your doctor or a qualified pharmacist.
How common is this variant?
The minor allele frequency for rs599609 is approximately 20-25% in European populations, making it a relatively common genetic variant.
Frequently asked questions
Is rs599609 a cause of heart disease?
No, rs599609 is not a direct cause of heart disease. It is a genetic marker associated with cholesterol levels, which are one of many factors that contribute to cardiovascular health.
Should I change my diet based on my rs599609 result?
You should not make significant dietary changes based solely on a genetic test result. Always consult with a registered dietitian or your doctor to create a heart-healthy plan tailored to your specific health needs.
Does this variant mean I have high cholesterol?
Not necessarily. While this variant is associated with cholesterol levels, your actual cholesterol is determined by a combination of your genetics, diet, exercise, and other environmental factors.
Can I use this information to predict my risk of a heart attack?
Genetic variants like rs599609 provide only a small amount of information regarding overall risk. Clinical risk assessment by a physician is the only reliable way to evaluate your cardiovascular health.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs599609?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SORT1
Functional regulatory variant altering SORT1 hepatic expression, predisposing to altered LDL cholesterol levels and myocardial infarction risk.
Variant in SORT1 significantly associated with LDL cholesterol levels and coronary artery disease risk.
Functional regulatory variant at the 1p13 locus that alters hepatic SORT1 expression, modulating plasma LDL-C levels and coronary artery disease risk.
This variant influences LDL cholesterol levels and is a significant marker for cardiovascular health.
This SNP is linked to variations in LDL cholesterol levels and risk of coronary artery disease.
